Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa for Late Anemia in Neonates with HDFN
NCT03104426Phase 3Unknown
- Sponsor
- J.J. van Rood Center for Clinical Transfusion Research
- Start
- Oct 2017
- Primary completion
- Aug 2020
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of darbepoetin alfa in anemia (2 arms), sponsored by J.J. van Rood Center for Clinical Transfusion Research. Primary endpoint: Number of top-up transfusions required per infant at 3 months. Status: unknown.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03104426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104426.